Enhanced Bioremediation of Chromium and Lead from Industrial Effluents using Mutated and Immobilized Bacillus subtilis and Bacillus amyloliquifaciens
Research Journal of Chemistry and Environment · 31.07.2026 · 30 (9) · 79
DOI: 10.25303/309rjce079084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Chemistry and Environment, online erschienen am 31.07.2026. Verfasst von Vatsala Tomar.
Abstract (Originalsprache)
Effluents released by industries containing chromium and lead exhibit adverse effects on the environment. This research focuses on studying the efficacy of Bacillus subtilis and Bacillus amyloliquifaciens along with their mutant counterpart for the removal of hexavalent chromium [Cr(VI)] and divalent lead [Pb(II)]. Strains native to industries were isolated and then exposed to UV and chemical mutagens to increase their efficiency in removing heavy metals. It was observed that chemical mutants exhibited higher performance compared to wild-type strains, successfully removing 100% of chromium (100 mg/L in 14 hours) and 97% of lead (474 mg/L in 18 days). The use of immobilization and consortia increased the rate of removal.
Zitieren
APA
Tomar, V. (2026). Enhanced Bioremediation of Chromium and Lead from Industrial Effluents using Mutated and Immobilized Bacillus subtilis and Bacillus amyloliquifaciens. Research Journal of Chemistry and Environment, 30(9), 79. https://doi.org/10.25303/309rjce079084
Vancouver
Tomar V. Enhanced Bioremediation of Chromium and Lead from Industrial Effluents using Mutated and Immobilized Bacillus subtilis and Bacillus amyloliquifaciens. Research Journal of Chemistry and Environment. 2026;30(9):79. doi:10.25303/309rjce079084
BibTeX
@article{Tomar2026,
author = {Tomar, Vatsala},
title = {Enhanced Bioremediation of Chromium and Lead from Industrial Effluents using Mutated and Immobilized Bacillus subtilis and Bacillus amyloliquifaciens},
journal = {Research Journal of Chemistry and Environment},
year = {2026},
volume = {30},
number = {9},
pages = {79},
doi = {10.25303/309rjce079084}
}
EUVIMED